↓ Skip to main content

Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)

Overview of attention for article published in Cardiovascular Diabetology, January 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
72 Dimensions

Readers on

mendeley
157 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)
Published in
Cardiovascular Diabetology, January 2020
DOI 10.1186/s12933-019-0977-z
Pubmed ID
Authors

Ayako Fuchigami, Fumika Shigiyama, Toru Kitazawa, Yosuke Okada, Takamasa Ichijo, Mariko Higa, Toru Hiyoshi, Ikuo Inoue, Kaoru Iso, Hidenori Yoshii, Takahisa Hirose, Naoki Kumashiro

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 157 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 157 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 22 14%
Student > Master 15 10%
Researcher 8 5%
Other 8 5%
Student > Postgraduate 7 4%
Other 18 11%
Unknown 79 50%
Readers by discipline Count As %
Medicine and Dentistry 43 27%
Biochemistry, Genetics and Molecular Biology 10 6%
Nursing and Health Professions 7 4%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Unspecified 3 2%
Other 9 6%
Unknown 81 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 July 2020.
All research outputs
#18,732,892
of 23,220,133 outputs
Outputs from Cardiovascular Diabetology
#1,077
of 1,418 outputs
Outputs of similar age
#334,684
of 456,614 outputs
Outputs of similar age from Cardiovascular Diabetology
#20
of 26 outputs
Altmetric has tracked 23,220,133 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,418 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.1. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 456,614 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.